Personalized health technology faces a significant gap in its ability to account for chronic conditions despite growing industry optimism [1].
This discrepancy matters because the push toward AI-driven healthcare could marginalize patients with complex needs if algorithms prioritize simplified data over medical reality. While some sectors see a path toward efficiency, others warn that the technology is not yet ready for the nuances of long-term illness.
Victoria Song, a senior reviewer for The Verge's Optimizer newsletter, analyzed the promises and pitfalls of these tools [1]. Song has more than 13 years of experience reporting on wearables [1]. Song said current algorithms still have a long way to go before they can effectively factor in chronic conditions [1].
This technical limitation stands in contrast to views from the insurance sector. A report from Forbes said that AI makes personalized health insurance possible [2]. This shift toward personalization aims to tailor insurance coverage to the specific needs, and behaviors, of the individual [2].
However, the integration of chronic disease management remains a primary hurdle. The current state of the technology creates a divide between the theoretical capability of AI to organize data and the practical application of that data in a clinical setting [1, 2].
As these tools proliferate, the risk remains that personalized health will only serve those with standard health profiles. The ability to incorporate complex medical histories into a digital framework is essential for equitable care, a goal that current algorithmic tools have yet to achieve [1].
“Algorithms still have a long way to go before they can factor in chronic conditions”
The conflict between the optimism of the insurance industry and the technical warnings of health tech analysts suggests a looming tension in healthcare delivery. If AI-driven insurance models are deployed before algorithms can accurately process chronic conditions, there is a risk of systemic under-coverage or inaccurate risk assessment for the most vulnerable patient populations.
